QuantaMatrix’s direct Rapid Antimicrobial Susceptibility Testing system (dRAST) improves optimal prescription of antibiotics by two days compared to conventional methods
Following successful validation of dRAST platform in Europe at key reference laboratories, system now adopted for clinical use
![Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use](https://ala.associates/wp-content/uploads/2021/12/dRAST_packshot_angle_main_screen_300dpi-1080x675.png)